+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Intratympanic methylprednisolone perfusion as a salvage treatment for profound idiopathic sudden sensorineural hearing loss



Intratympanic methylprednisolone perfusion as a salvage treatment for profound idiopathic sudden sensorineural hearing loss



Journal of Laryngology and Otology 131(5): 404-410



This study aimed to examine the effectiveness of intratympanic methylprednisolone perfusion as salvage treatment for profound idiopathic sudden sensorineural hearing loss. A retrospective clinical study of 97 patients with unilateral profound idiopathic sudden sensorineural hearing loss was performed. In all, 83 patients who received salvage intratympanic methylprednisolone perfusion plus conventional treatment (except for steroids) as the second-line therapy were assigned to the study group, while 14 patients who received conventional treatment alone were assigned to the comparison group. In the study group, treatments in patients with a shorter interval from disease onset to intratympanic methylprednisolone perfusion (up to 15 days) had significantly greater improvements in the overall effective rate and pure tone average compared with patients with a longer interval (over 15 days). For patients with a short interval from disease onset to intratympanic methylprednisolone perfusion, those in the study group had significantly greater improvements in the overall effective rate and pure tone average compared with those in the comparison group. In both the study and comparison groups, hearing improvements were greater at low frequencies than at medium and high frequencies. The interval from disease onset to intratympanic methylprednisolone perfusion was the major factor affecting hearing recovery. Early second-line salvage intratympanic methylprednisolone perfusion significantly improved the degree of hearing recovery in profound idiopathic sudden sensorineural hearing loss patients after failure of systemic steroid treatment.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 059881058

Download citation: RISBibTeXText

PMID: 28290919

DOI: 10.1017/s0022215117000548


Related references

Hearing Efficacy of Intratympanic Methylprednisolone Perfusion for Severe and Profound Sudden Sensorineural Hearing Loss. Otolaryngology - Head and Neck Surgery 151(1 Suppl.): P207-P207, 2014

Intratympanic steroids as a salvage therapy for severe to profound idiopathic sudden sensorineural hearing loss. Acta Oto-Laryngologica 2018: 1-6, 2018

Intratympanic steroids in severe to profound sudden sensorineural hearing loss as salvage treatment. Clinical and Experimental Otorhinolaryngology 3(3): 122-125, 2010

Intratympanic steroid administration: use in the treatment of profound idiopathic sudden sensorineural hearing loss. Hno 61(2): 152, 154-8, 2013

Intratympanic Methylprednisolone versus Dexamethasone for the Primary Treatment of Idiopathic Sudden Sensorineural Hearing Loss. Journal of International Advanced Otology 2018, 2018

Efficacy of intratympanic corticosteroid as a salvage treatment in idiopathic sudden sensorineural hearing loss. Acta Otorrinolaringologica Espanola 2018, 2018

Efficacy of Intratympanic Steroid Therapy as a Salvage Treatment for Idiopathic Sudden Sensorineural Hearing Loss. Otolaryngology - Head and Neck Surgery 149(2 Suppl.): P223-P224, 2013

Intratympanic dexamethasone for profound idiopathic sudden sensorineural hearing loss. Otolaryngology--Head and Neck Surgery 132(6): 902-905, 2005

Hearing evaluation of intratympanic methylprednisolone perfusion for refractory sudden sensorineural hearing loss. Otolaryngology--Head and Neck Surgery 142(6): 922-3; Author Reply 923, 2010

Intratympanic methylprednisolone perfusion remedy refractory sudden sensorineural hearing loss. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 31(7): 496-499, 2018

Efficacy of low-dose intratympanic dexamethasone as a salvage treatment for idiopathic sudden sensorineural hearing loss: the Modbury Hospital experience. Journal of Laryngology and Otology 128(Suppl. 2): S27-S30, 2015

Daily short-term intratympanic dexamethasone treatment alone as an initial or salvage treatment for idiopathic sudden sensorineural hearing loss. Audiology and Neuro-Otology 16(3): 191-197, 2011

Histone Deacetylase 2 in Sudden Sensorineural Hearing Loss Patients in Response to Intratympanic Methylprednisolone Perfusion. Otolaryngology -- Head and Neck Surgery, 2015

Intratympanic Dexamethasone after High-Dose Intravenous Methylprednisolone in Idiopathic Sudden Sensorineural Hearing Loss. Otolaryngology - Head and Neck Surgery 151(1 Suppl.): P88-P88, 2014

Salvage Intratympanic Steroid Therapy for Refractory Idiopathic Sudden Sensorineural Hearing Loss. Otolaryngology - Head and Neck Surgery 149(2 Suppl.): P237-P237, 2013